Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. Announces Exchange Offer for its 9 1/4% Senior Subordinated Notes Due 2011
DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9…
-
Davita Announces Second Quarter Earnings Release
We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on…
-
Nancy-Ann DeParle and William L. Roper Join DaVita Board of Directors
DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors…
-
DaVita says price of Amgen’s Epogen raised 3.9 pct
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) – DaVita Inc. (NYSE:DVA), an…
-
Amgen Raises EPOGEN Pricing
DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing…